Leiming You - Search Results

Year	Number of Results
2008	1
2009	4
2010	4
2013	1
2014	2
2015	3
2016	1
2018	1
2019	1
2020	2
2021	3
2022	4
2023	7
2024	2

1

Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma.

Huang J, Zhang J, Zhang F, Lu S, Guo S, Shi R, Zhai Y, Gao Y, Tao X, Jin Z, You L, Wu J. Huang J, et al. Among authors: you l. Comput Biol Med. 2023 Oct;165:107402. doi: 10.1016/j.compbiomed.2023.107402. Epub 2023 Aug 28. Comput Biol Med. 2023. PMID: 37657358 Free article.

2

Compound Kushen Injection inhibits epithelial-mesenchymal transition of gastric carcinoma by regulating VCAM1 induced by the TNF signaling pathway.

Huang Z, Wu C, Zhou W, Lu S, Tan Y, Wu Z, You R, Stalin A, Guo F, Zhang J, Liu P, Wang W, Duan X, You L, Wu J. Huang Z, et al. Among authors: you l. Phytomedicine. 2023 Sep;118:154984. doi: 10.1016/j.phymed.2023.154984. Epub 2023 Jul 17. Phytomedicine. 2023. PMID: 37487253 Free article.

3

Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.

Zhai Y, Liu X, Huang Z, Zhang J, Stalin A, Tan Y, Zhang F, Chen M, Shi R, Huang J, Wu C, Wu Z, Lu S, You L, Wu J. Zhai Y, et al. Among authors: you l. Sci Rep. 2023 Jan 25;13(1):1373. doi: 10.1038/s41598-023-28234-7. Sci Rep. 2023. PMID: 36697459 Free PMC article.

4

Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.

Wu Z, Wu C, Shi J, Huang Z, Lu S, Tan Y, You R, Hai L, Huang J, Guo S, Gao Y, Jin Z, Tao X, You L, Wu J. Wu Z, et al. Among authors: you l. J Ethnopharmacol. 2023 Oct 28;315:116702. doi: 10.1016/j.jep.2023.116702. Epub 2023 May 29. J Ethnopharmacol. 2023. PMID: 37257705 Free article.

5

Single-Cell and Bulk RNA Sequencing Reveal Malignant Epithelial Cell Heterogeneity and Prognosis Signatures in Gastric Carcinoma.

Huang Z, Wu C, Liu X, Lu S, You L, Guo F, Stalin A, Zhang J, Zhang F, Wu Z, Tan Y, Fan X, Huang J, Zhai Y, Shi R, Chen M, Wu C, Li H, Wu J. Huang Z, et al. Among authors: you l. Cells. 2022 Aug 17;11(16):2550. doi: 10.3390/cells11162550. Cells. 2022. PMID: 36010627 Free PMC article.

6

The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.

Lu S, Huang J, Zhang J, Wu C, Huang Z, Tao X, You L, Stalin A, Chen M, Li J, Tan Y, Wu Z, Geng L, Li Z, Fan Q, Liu P, Lin Y, Zhao C, Wu J. Lu S, et al. Among authors: you l. J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117209. doi: 10.1016/j.jep.2023.117209. Epub 2023 Sep 25. J Ethnopharmacol. 2024. PMID: 37757991 Free article.

7

Xijiao Dihuang decoction combined with Yinqiao powder promotes autophagy-dependent ROS decrease to inhibit ROS/NLRP3/pyroptosis regulation axis in influenza virus infection.

Deng D, Zhao M, Liu H, Zhou S, Liu H, You L, Hao Y. Deng D, et al. Among authors: you l. Phytomedicine. 2024 Jun;128:155446. doi: 10.1016/j.phymed.2024.155446. Epub 2024 Feb 10. Phytomedicine. 2024. PMID: 38518643

8

Berberine ameliorates pulmonary inflammation in mice with influenza viral pneumonia by inhibiting NLRP3 inflammasome activation and gasdermin D-mediated pyroptosis.

An C, Wu Y, Wu J, Liu H, Zhou S, Ge D, Dong R, You L, Hao Y. An C, et al. Among authors: you l. Drug Dev Res. 2022 Nov;83(7):1707-1721. doi: 10.1002/ddr.21995. Epub 2022 Sep 16. Drug Dev Res. 2022. PMID: 36112730

9

A New Strategy to Identify ceRNA-Based CCDC144NL-AS1/SERPINE1 Regulatory Axis as a Novel Prognostic Biomarker for Stomach Adenocarcinoma via High Throughput Transcriptome Data Mining and Computational Verification.

Huang Z, Liu X, Wu C, Lu S, Antony S, Zhou W, Zhang J, Wu Z, Tan Y, Fan X, You L, Jing Z, Wu J. Huang Z, et al. Among authors: you l. Front Oncol. 2022 Jan 27;11:802727. doi: 10.3389/fonc.2021.802727. eCollection 2021. Front Oncol. 2022. PMID: 35155200 Free PMC article.

10

An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.

Lu S, Meng Z, Tan Y, Wu C, Huang Z, Huang J, Fu C, Stalin A, Guo S, Liu X, You L, Li X, Zhang J, Zhou W, Zhang X, Wang M, Wu J. Lu S, et al. Among authors: you l. BMC Complement Med Ther. 2022 Mar 2;22(1):54. doi: 10.1186/s12906-022-03530-3. BMC Complement Med Ther. 2022. PMID: 35236335 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year